AUA Summit - Bladder Cancer Caregivers – Getting More Informed with Dr. Sima Porten


Centro de recursos Patient Magazine Podcast Donate

Attention: Restrictions on use of AUA, AUAER, and UCF content in third party applications, including artificial intelligence technologies, such as large language models and generative AI.
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.

Bladder Cancer Caregivers – Getting More Informed with Dr. Sima Porten

Headshot of Dr. Sima Porten.

This podcast is part of the Bladder Cancer Caregivers Podcast series, a series to help provide more understanding and guidance for people impacted by bladder cancer, to include friends, family and caregivers. Our guest is Dr. Sima Porten, a urologic oncologist at the University of California, San Francisco. The goal of this podcast is to help patients and caregivers with tools for shared decision making about diagnosis and treatment for bladder cancer.

Short on time? Use the below timestamps to jump to any section:
1:04 - Introduction
1:19 - Overview, symptoms and who is most affected by bladder cancer
3:12 - Most common treatment options
6:38 - Genetic testing for bladder cancer
10:02 - Getting more informed about treatment options
12:13 - Questions to ask your doctor
15:26 - Advice for those living with bladder cancer and caregivers
17:18 - Final thoughts 

Patient resources provided through the generous support of Seagen and Astellas.

For more information, subscribe to our free digital magazine, UrologyHealth extra.

April 6, 2023

Explore Further

Share Your Story

Have a story to share? The Urology Care Foundation invites you to share your experience with a urologic condition and how it has affected you or your family.

Make a Differnece

Your tax-deductible gift will help support the millions of patients who are faced with urologic disease. Together, we care.